Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Vu Hong Thang, Edneia Tani, Hemming Johansson, Jan Adolfsson, Kamilla Krawiec, Ta Thanh Van & Lambert Skoog. (2011) Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women. Acta Oncologica 50:3, pages 353-359.
Read now
Read now
Margareta Palm Sjövall & Per Malmström. (1997) Induction Chemotherapy with Versus Without Hormonal Synchronisation in Locally Advanced Breast Cancer. Acta Oncologica 36:2, pages 207-212.
Read now
Read now
Mårten Fernö, Christina Andersson, Ghita Fallenius & Ingrid Idvall. (1996) Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment. Acta Oncologica 35:1, pages 17-22.
Read now
Read now
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud & Thomas Hatschek. (1992) Interrelations Between Cellular DNA Content, S-Phase Fraction, Hormone Receptor Status and Age in Primary Breast Cancer A Series of 1 342 Consecutively Detected Tumors. Acta Oncologica 31:3, pages 283-292.
Read now
Read now
MÅRten Fernö, Bo Baldetorp, ÅKe Borg, HÅKan Olsson, Helgi Sigurdsson & Dick Killander. (1992) Flow Cytometric DNA Index and S-Phase Fraction in Breast Cancer in Relation to Other Prognostic Variables and to Clinical Outcome. Acta Oncologica 31:2, pages 157-165.
Read now
Read now
Sven Börje Ewers, Robyn Attewell, Bo Baldetorp, Aring;ke Borg, Mårten Fernö, Eva Långström, Stefa Rydén & Dick Killander. (1992) Flow Cytometry Dna Analysis and Prediction of Loco-Regional Recurrences After Mastectomy in Breast Cancer. Acta Oncologica 31:7, pages 733-740.
Read now
Read now
Articles from other publishers (38)
Maria Simonsson, Srinivas Veerla, Andrea Markkula, Carsten Rose, Christian Ingvar & Helena Jernström. (2016) CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients. BMC Cancer 16:1.
Crossref
Crossref
Naoko Honma, Rie Horii, Yoshinori Ito, Shigehira Saji, Mamoun Younes, Takuji Iwase & Futoshi Akiyama. (2015) Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. BMC Cancer 15:1.
Crossref
Crossref
Maria Simonsson, Viktoria Söderlind, Maria Henningson, Maria Hjertberg, Carsten Rose, Christian Ingvar & Helena Jernström. (2013) Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes & Control 24:5, pages 929-940.
Crossref
Crossref
Mohammad Hossein Hajiebrahimi, Shahram Bahmanyar, Mats Lambe, Jan Adolfsson, Tommy Fornander, Fredrik Wärnberg & Sven Cnattingius. (2012) Placental weight and mortality in premenopausal breast cancer by tumor characteristics. Breast Cancer Research and Treatment 137:1, pages 297-305.
Crossref
Crossref
Mara A. SchonbergEdward R. MarcantonioDonglin LiRebecca A. SillimanLong NgoEllen P. McCarthy. (2010) Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival. Journal of Clinical Oncology 28:12, pages 2038-2045.
Crossref
Crossref
Hua Bing Zhang, Ji Jun Xue, Xiao Long Zhao, De Gang Liu & Ying Li. (2009) Synthesis and biological evaluation of novel steroid-linked nitrogen mustards. Chinese Chemical Letters 20:6, pages 680-683.
Crossref
Crossref
David J. Winchester & David P. Winchester. 2009. The Breast. The Breast
1339
1348
.
Lobna Ayadi, Abdelmajid Khabir, Habib Amouri, Sondes Karray, Abdallah Dammak, Mohamed Guermazi & Tahya Boudawara. (2008) Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma. World Journal of Surgical Oncology 6:1.
Crossref
Crossref
Dalia M. Abd El‐Rehim, Graham Ball, Sarah E. Pinder, Emad Rakha, Claire Paish, John F.R. Robertson, Douglas Macmillan, Roger W. Blamey & Ian O. Ellis. (2005) High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. International Journal of Cancer 116:3, pages 340-350.
Crossref
Crossref
Dalia M Abd El‐Rehim, Sarah E Pinder, Claire E Paish, J Bell, RW Blamey, John FR Robertson, Robert I Nicholson & Ian O Ellis. (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. The Journal of Pathology 203:2, pages 661-671.
Crossref
Crossref
Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist & Heli Nevanlinna. (2004) Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families. Breast Cancer Research 7:1.
Crossref
Crossref
N Honma, G Sakamoto, F Akiyama, Y Esaki, M Sawabe, T Arai, T Hosoi, N Harada, M Younes & K Takubo. (2003) Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 42:2, pages 120-127.
Crossref
Crossref
S.-D Costa, S Lange, K Klinga, E Merkle & M Kaufmann. (2002) Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer—results of the analysis of 670 patients with 11 years of follow-up. European Journal of Cancer 38:10, pages 1329-1334.
Crossref
Crossref
Anjila Koul, Roger Willén, Pär‐Ola Bendahl, Mef Nilbert & Åke Borg. (2002) Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 94:9, pages 2369-2379.
Crossref
Crossref
Kaushik Mitra, John C. Marquis, Shawn M. Hillier, Peter T. Rye, Beatriz Zayas, Annie S. Lee, John M. Essigmann & Robert G. Croy. (2002) A Rationally Designed Genotoxin that Selectively Destroys Estrogen Receptor-Positive Breast Cancer Cells. Journal of the American Chemical Society 124:9, pages 1862-1863.
Crossref
Crossref
John M. Essigmann, Stacia M. Rink, Hyun-Ju Rink & Robert G. Croy. 2001. Biological Reactive Intermediates VI. Biological Reactive Intermediates VI
301
313
.
H Olsson. (2000) Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation — a hypothesis. The Journal of Steroid Biochemistry and Molecular Biology 74:5, pages 345-350.
Crossref
Crossref
A. Koul, S. Malander, N. Loman, T. Pejovic, S. Heim, R. Willen, O. Johannsson, H. Olsson, M. Ridderheim & A. Borg. (2000) BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features. International Journal of Gynecological Cancer 10:4, pages 289-295.
Crossref
Crossref
Qing He, Cynthia H. Liang & Stephen J. Lippard. (2000) Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proceedings of the National Academy of Sciences 97:11, pages 5768-5772.
Crossref
Crossref
Kerstin Struse, Werner Audretsch, Mahdi Rezai, Guido Pott & Hans Bojar. (2000) The Estrogen Receptor Paradox in Breast Cancer: Association of High Receptor Concentrations with Reduced Overall Survival. The Breast Journal 6:2, pages 115-125.
Crossref
Crossref
Niklas Loman, Oskar Johannsson, P�r-Ola Bendahl, �ke Borg, M�rten Fern� & H�kan Olsson. (1999) Author reply. Cancer 85:10, pages 2293-2295.
Crossref
Crossref
Jacqueline Ashba & Abdulmaged M. Traish. (1999) Estrogen and Progesterone Receptor Concentrations and Prevalence of Tumor Hormonal Phenotypes in Older Breast Cancer Patients. Cancer Detection <html_ent glyph="@amp;" ascii="&"/> Prevention 23:3, pages 238-244.
Crossref
Crossref
David J. Winchester. 1999. Breast Cancer. Breast Cancer
284
293
.
Pascal Pujol, Jean-Pierre Daures, Simon Thezenas, Fan�oise Guilleux, Phillipe Rouanet & Jean Grenier. (1998) Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer 83:4, pages 698-705.
Crossref
Crossref
Niklas Loman, Oskar Johannsson, P�r-Ola Bendahl, �ke Borg, M�rten Fern� & H�kan Olsson. (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:2, pages 310-319.
Crossref
Crossref
Anjila Koul, Åke Borg, Tanja Pejovic, Pär-Ola Bendahl, Thomas Högberg, Constantin S. Iosif & Dick Killander. (1997) Identification of TP53 Gene Mutations in Uterine Corpus Cancer with Short Follow-up. Gynecologic Oncology 67:3, pages 295-302.
Crossref
Crossref
Max Görlich & Burkhard Jandrig. (2018) Steroid Hormone Receptors Related to Parameters Characterizing the Biology of Human Breast Cancer. Tumori Journal 83:6, pages 930-937.
Crossref
Crossref
S Romain, F Spyratos, J Goussard, JL Formento & H Magdelénat. (1997) Amélioration du contrôle de qualité pour les dosages de récepteurs stéroïdiens: analyse des distributions dans plus de 40 000 cancers primitifs du sein. Immuno-analyse & Biologie Spécialisée 12:1, pages 21-23.
Crossref
Crossref
Stacia M. Rink, Kevin J. Yarema, Marjorie S. Solomon, Lisa A. Paige, B. Mitra Tadayoni-Rebek, John M. Essigmann & Robert G. Croy. (1996) Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor. Proceedings of the National Academy of Sciences 93:26, pages 15063-15068.
Crossref
Crossref
David J. Winchester. (1996) Male breast cancer. Seminars in Surgical Oncology 12:5, pages 364-369.
Crossref
Crossref
Sylvie Romain, Frédérique Spyratos, Jacques Goussard, Jean-Louis Formento & Henri Magdelénat. (1996) Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers. Breast Cancer Research and Treatment 41:2, pages 131-139.
Crossref
Crossref
M�rten Fern�, Bo Baldetorp, P�r-Ola Bendahl, �ke Borg, Sven-B�rje Ewers, H�kan Olsson, Stefan Ryd�n, Helgi Sigurdsson & Dick Killander. (1995) Recurrence-free survival in breast cancer improved by adjuvant tamoxifen -especially for progesterone receptor positive tumors with a high proliferation. Breast Cancer Research and Treatment 36:1, pages 23-34.
Crossref
Crossref
Helge Stalsberg, David B. Thomas, Karin A. Rosenblatt, L. Margarita Jimenez, Anne McTiernan, Annette Stemhagen, W. Douglas Thompson, Mary G. McCrea Curnen, William Satariano, Donald F. Austin, Raymond S. Greenberg, Charles Key, Laurence Kolonel & Dee West. (1993) Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes and Control 4:2, pages 143-151.
Crossref
Crossref
S.M. Thorpe, I.J. Christensen, B.B. Rasmussen & C. Rose. (1993) Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. European Journal of Cancer 29:7, pages 971-977.
Crossref
Crossref
Sven-Börje Ewers, Robyn Attewell, Bo Baldetorp, Åke Borg, Mårten Fernö, Eva Långström & Dick Killander. (1992) Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas — a 10 year survival study. Breast Cancer Research and Treatment 24:2, pages 115-126.
Crossref
Crossref
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud, Thomas Hatschek & Bo Nordenskjöld. (2006) Relationships of DNA ploidy, S‐phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. International Journal of Cancer 51:1, pages 28-33.
Crossref
Crossref
David N. DanforthJr.Jr.. (1992) Hormone receptors in malignancy. Critical Reviews in Oncology/Hematology 12:2, pages 91-149.
Crossref
Crossref
Joseph Monsonego, Henri Magdelenat, François Catalan, Yves Coscas, Laurent Zerat & Xavier Sastre. (2006) Estrogen and progesterone receptors in cervical human papillomavirus related lesions. International Journal of Cancer 48:4, pages 533-539.
Crossref
Crossref